 Myocardial Ischemia
"Myocardial Ischemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Descriptor ID |
D017202
|
| MeSH Number(s) |
C14.280.647 C14.907.585
|
| Concept/Terms |
Myocardial Ischemia- Myocardial Ischemia
- Ischemia, Myocardial
- Ischemias, Myocardial
- Myocardial Ischemias
- Ischemic Heart Disease
- Heart Disease, Ischemic
- Disease, Ischemic Heart
- Diseases, Ischemic Heart
- Heart Diseases, Ischemic
- Ischemic Heart Diseases
|
Below are MeSH descriptors whose meaning is more general than "Myocardial Ischemia".
Below are MeSH descriptors whose meaning is more specific than "Myocardial Ischemia".
This graph shows the total number of publications written about "Myocardial Ischemia" by people in this website by year, and whether "Myocardial Ischemia" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 4 | 3 | 7 | | 1994 | 2 | 1 | 3 | | 1995 | 3 | 3 | 6 | | 1996 | 10 | 4 | 14 | | 1997 | 6 | 1 | 7 | | 1998 | 5 | 5 | 10 | | 1999 | 5 | 5 | 10 | | 2000 | 11 | 1 | 12 | | 2001 | 5 | 2 | 7 | | 2002 | 5 | 4 | 9 | | 2003 | 6 | 1 | 7 | | 2004 | 3 | 2 | 5 | | 2005 | 4 | 5 | 9 | | 2006 | 9 | 2 | 11 | | 2007 | 5 | 3 | 8 | | 2008 | 2 | 4 | 6 | | 2009 | 3 | 1 | 4 | | 2010 | 1 | 2 | 3 | | 2011 | 8 | 3 | 11 | | 2012 | 9 | 2 | 11 | | 2013 | 4 | 1 | 5 | | 2014 | 7 | 2 | 9 | | 2015 | 6 | 1 | 7 | | 2016 | 10 | 4 | 14 | | 2017 | 2 | 3 | 5 | | 2018 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Myocardial Ischemia" by people in Profiles.
-
Sweet ME, Cocciolo A, Slavov D, Jones KL, Sweet JR, Graw SL, Reece TB, Ambardekar AV, Bristow MR, Mestroni L, Taylor MRG. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure. BMC Genomics. 2018 Nov 12; 19(1):812.
-
Tran M, Pesah E, Turk-Adawi K, Supervia M, Lopez Jimenez F, Oh P, Baer C, Grace SL. Cardiac Rehabilitation Availability and Delivery in Canada: How Does It Compare With Other High-Income Countries? Can J Cardiol. 2018 10; 34(10 Suppl 2):S252-S262.
-
Salame G, Juselius WE, Burden M, Long CS, Bendelow T, Beaty B, Masoudi FA, Krantz MJ. Contrast-Enhanced Stress Echocardiography and Myocardial Perfusion Imaging in Patients Hospitalized With Chest Pain: A Randomized Study. Crit Pathw Cardiol. 2018 06; 17(2):98-104.
-
Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Bansilal S, Bhatt DL, Leiter LA, McGuire DK, Wilding JP, Gause-Nilsson IA, Langkilde AM, Johansson PA, Sabatine MS. The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial. Am Heart J. 2018 06; 200:83-89.
-
Travers JG, Kamal FA, Valiente-Alandi I, Nieman ML, Sargent MA, Lorenz JN, Molkentin JD, Blaxall BC. Pharmacological and Activated Fibroblast Targeting of Gß?-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression. J Am Coll Cardiol. 2017 Aug 22; 70(8):958-971.
-
Lu L, Ye S, Scalzo RL, Reusch JEB, Greyson CR, Schwartz GG. Metformin prevents ischaemic ventricular fibrillation in metabolically normal pigs. Diabetologia. 2017 08; 60(8):1550-1558.
-
Marzec LN, Peterson PN, Bao H, Curtis JP, Masoudi FA, Varosy PD, Bradley SM. Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry. JAMA Cardiol. 2017 05 01; 2(5):561-565.
-
Patel AC, Dodson RB, Cornwell WK, Hunter KS, Cleveland JC, Brieke A, Lindenfeld J, Ambardekar AV. Dynamic Changes in Aortic Vascular Stiffness in Patients Bridged to Transplant With Continuous-Flow Left Ventricular Assist Devices. JACC Heart Fail. 2017 06; 5(6):449-459.
-
Oyama Y, Bartman CM, Gile J, Eckle T. Circadian MicroRNAs in Cardioprotection. Curr Pharm Des. 2017; 23(25):3723-3730.
-
Sharma S, Kwan S, Fallano KA, Wang J, Miller NR, Subramanian PS. Comparison of Visual Outcomes of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients with and without Diabetes Mellitus. Ophthalmology. 2017 04; 124(4):450-455.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|